Growth Hormone Disorder: Clinical Trials

4 trials for Growth Hormone Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 3, Terminated 1

Follow Growth Hormone Disorder: new trials by email Literature Review of Growth Hormone Disorder trials Research Report on Growth Hormone Disorder

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents
Norditropin NordiFlex® - Growth Hormone Disorder, Growth Hormone Deficiency in Children
Phase 4CompletedNovo Nordisk A/S1032010-11-012017-02-27
Liquid Somatropin Formulation in Children With Growth Hormone Deficiency
somatropin - Growth Hormone Disorder, Growth Hormone Deficiency in Children
Phase 4CompletedNovo Nordisk A/S1762003-03-102017-02-28
Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency
somatropin - Growth Hormone Disorder, Adult Growth Hormone Deficiency
Phase 4TerminatedNovo Nordisk A/S72001-05-162017-02-27
Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients
somatropin, placebo - Growth Hormone Disorder, Adult Growth Hormone Deficiency
Phase 4CompletedNovo Nordisk A/S221998-10-212024-02-28

Narrower conditions

Dwarfism, Pituitary (2)  ·  Genetic Diseases, Inborn (1)  ·  Renal Insufficiency, Chronic (1)  ·  Turner Syndrome (1)

Broader conditions

Endocrine System Diseases (3)  ·  Bone Diseases (2)  ·  Bone Diseases, Developmental (2)  ·  Bone Diseases, Endocrine (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Dwarfism (2)  ·  Hypopituitarism (2)  ·  Hypothalamic Diseases (2)  ·  Musculoskeletal Diseases (2)  ·  Nervous System Diseases (2)  ·  Pituitary Diseases (2)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Chromosome Disorders (1)

Interventions

Human Growth Hormone (3)

Sponsors

Novo Nordisk A/S (4)

Countries

France (2)  ·  Greece (1)  ·  Turkey (Türkiye) (1)

Results publications

PMID 23737664

NIH funding

2009 (1)